(HealthDay News) -- Here are the latest clinical trials,
This study of moderate-to-severe plaque psoriasis will compare
an investigational combination of two FDA-approved drugs with a
single approved psoriasis medication.
The research site is in Denver, Colo.
To qualify for this study, candidates must be aged 21 to 64,
have trouble staying asleep, and be in general good health.
The research site is in New York City.
This 12-week study will evaluate the safety and effectiveness of
the study drug in eliminating hot flashes in post-menopausal women.
Participants must be 40 or older and have 50 to 60 hot flashes per
The research site is in Sacramento, Calif.
ClinicalConnection.com. All rights reserved.